Study supports new screening method for cervical cancer
Vari Drennan Professor, Healthcare and policy research at Kingston University and St George’s, University of London
A national roll-out of screening for routine primary high risk human papillomavirus (hrHPV) is under way in England. To support it, a large pilot study of routine testing for hrHPV examined the prevalence and incidence of cervical intraepithelial neoplasia (CIN, the pre-cancerous abnormalities) and cancer, comparing it with liquid-based cytology (LBC).
Primary Health Care.
29, 2, 13-13.
doi: 10.7748/phc.29.2.13.s11
Want to read more?
Subscribe for unlimited access
Try 1 month’s access for just £1 and get:
Your subscription package includes:
- Full access to the website and the online archive
- Bi-monthly digital edition
- RCNi Portfolio and interactive CPD quizzes
- RCNi Learning with 200+ evidence-based modules
- 10 articles a month from any other RCNi journal
Subscribe
Already subscribed? Log in
Alternatively, you can purchase access to this article for the next seven days. Buy now
Or
